Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06045390 · ClinicalTrials.gov registry record · NA

An App-based Instructional Platform to Improve Eye Drop Recall

A NA study of Glaucoma, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06045390 is a NA study of Glaucoma that has completed, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06045390, a NA study of Glaucoma, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens. Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule. At one month, both groups will be assessed on their eye drop regimen recall.

Conditions Studied

Interventions

  • OTHER App

Study Locations (1)

California

  • San Francisco General Hospital - San Francisco

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-09-01
Est. Completion 2025-06-01
Phase NA

What the Registry Record Tells You About NCT06045390

The ClinicalTrials.gov registry entry for NCT06045390 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which App is the first listed.

NCT06045390 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06045390 about?

NCT06045390 is a clinical study titled "An App-based Instructional Platform to Improve Eye Drop Recall". The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens. Participants will be divided into two groups -- those who use the app and those who do not...

What is the current status of trial NCT06045390?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-09-01. Estimated completion is 2025-06-01.

What conditions does trial NCT06045390 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT06045390?

The interventions under investigation include: App (OTHER).

Who is sponsoring clinical trial NCT06045390?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06045390 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.